DRUGS company GlaxoSmithKline today praised the performance of five key disease treatments which have helped raise sales.
The pharmaceuticals giant said the drugs, which treat asthma to heart disease, helped boost sales by more than 18 per cent in the first quarter of 2004.
The chief executive, Jean-Pierre Garnier, said the company had made a good start to 2004 with US sales ahead by 10 per cent.
Full story in tomorrow's Northern Echo.
Comments: Our rules
We want our comments to be a lively and valuable part of our community - a place where readers can debate and engage with the most important local issues. The ability to comment on our stories is a privilege, not a right, however, and that privilege may be withdrawn if it is abused or misused.
Please report any comments that break our rules.
Read the rules hereComments are closed on this article